Merck KGaA Share Price

Equities

MRK

DE0006599905

Pharmaceuticals

Real-time Estimate Tradegate 07:32:02 13/06/2024 pm IST 5-day change 1st Jan Change
171.8 EUR -2.33% Intraday chart for Merck KGaA +0.26% +19.60%

Financials

Sales 2024 * 21.32B 23.03B 1,923B Sales 2025 * 22.64B 24.46B 2,042B Capitalization 76.46B 82.59B 6,894B
Net income 2024 * 3B 3.24B 270B Net income 2025 * 3.52B 3.8B 317B EV / Sales 2024 * 3.88 x
Net Debt 2024 * 6.19B 6.69B 558B Net Debt 2025 * 4.37B 4.72B 394B EV / Sales 2025 * 3.57 x
P/E ratio 2024 *
25.6 x
P/E ratio 2025 *
21.6 x
Employees 62,345
Yield 2024 *
1.32%
Yield 2025 *
1.45%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Merck KGaA

1 day-1.91%
1 week+0.26%
Current month+3.51%
1 month+11.55%
3 months+7.69%
6 months+27.24%
Current year+19.60%
More quotes
1 week
169.50
Extreme 169.5
176.25
1 month
155.10
Extreme 155.1
176.25
Current year
140.50
Extreme 140.5
176.25
1 year
134.30
Extreme 134.3
176.25
3 years
134.30
Extreme 134.3
231.50
5 years
76.22
Extreme 76.22
231.50
10 years
61.05
Extreme 61.05
231.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 13/20/13
Director of Finance/CFO 56 01/14/01
Director of Finance/CFO 54 26/19/26
Members of the board TitleAgeSince
Director/Board Member - -
Director/Board Member 61 01/12/01
Director/Board Member 62 01/91/01
More insiders
Date Price Change Volume
13/24/13 172.2 -2.05% 52 262
12/24/12 175.8 +2.36% 344,307
11/24/11 171.8 -0.06% 198,209
10/24/10 171.9 +0.35% 151,028
07/24/07 171.3 -0.35% 140,012

Delayed Quote Xetra, June 13, 2024 at 07:16 pm IST

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
175.8 EUR
Average target price
186.1 EUR
Spread / Average Target
+5.81%
Consensus